TYK Medicines, Inc (HKG:2410)

TYK Medicines Statistics

Total Valuation

TYK Medicines has a market cap or net worth of HKD 5.59 billion. The enterprise value is 5.34 billion.

Market Cap	5.59B
Enterprise Value	5.34B

Important Dates

The next estimated earnings date is Monday, December 1, 2025.

Earnings Date	Dec 1, 2025
Ex-Dividend Date	n/a

Share Statistics

TYK Medicines has 380.07 million shares outstanding. The number of shares has increased by 18.99% in one year.

Current Share Class	375.46M
Shares Outstanding	380.07M
Shares Change (YoY)	+18.99%
Shares Change (QoQ)	+4.50%
Owned by Insiders (%)	2.11%
Owned by Institutions (%)	22.82%
Float	227.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	47,650.86
PB Ratio	14.22
P/TBV Ratio	17.15
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-17.41
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-15.17

Financial Position

The company has a current ratio of 1.86, with a Debt / Equity ratio of 0.47.

Current Ratio	1.86
Quick Ratio	1.52
Debt / Equity	0.47
Debt / EBITDA	n/a
Debt / FCF	-0.53
Interest Coverage	-20.25

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-27.71%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-54.84%
Revenue Per Employee	719
Profits Per Employee	-1.88M
Employee Count	153
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.77% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-36.77%
50-Day Moving Average	15.49
200-Day Moving Average	22.01
Relative Strength Index (RSI)	44.43
Average Volume (20 Days)	5,455,954

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TYK Medicines had revenue of HKD 117,248 and -306.91 million in losses. Loss per share was -0.85.

Revenue	117,248
Gross Profit	15,341
Operating Income	-321.54M
Pretax Income	-309.51M
Net Income	-306.91M
EBITDA	-306.60M
EBIT	-321.54M
Loss Per Share	-0.85

Balance Sheet

The company has 430.56 million in cash and 186.12 million in debt, giving a net cash position of 244.44 million or 0.64 per share.

Cash & Cash Equivalents	430.56M
Total Debt	186.12M
Net Cash	244.44M
Net Cash Per Share	0.64
Equity (Book Value)	392.83M
Book Value Per Share	1.05
Working Capital	245.42M

Cash Flow

In the last 12 months, operating cash flow was -291.62 million and capital expenditures -60.66 million, giving a free cash flow of -352.27 million.

Operating Cash Flow	-291.62M
Capital Expenditures	-60.66M
Free Cash Flow	-352.27M
FCF Per Share	-0.93

Margins

Gross Margin	13.08%
Operating Margin	-274,243.18%
Pretax Margin	-263,982.39%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TYK Medicines does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.99%
Shareholder Yield	-18.99%
Earnings Yield	-5.49%
FCF Yield	-6.31%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TYK Medicines has an Altman Z-Score of 10.16 and a Piotroski F-Score of 2.

Altman Z-Score	10.16
Piotroski F-Score	2